Antiverse
Latest round
- Series A
Last raised
- Mar 2026
Total raised
- $19M
Investors
- 13
About Antiverse
Antiverse Ltd, based in the UK, specializes in innovative antibody design, utilizing advanced machine learning and engineering techniques to create therapeutics targeting complex drug targets. Founded in 2017 in Wales, UK, Antiverse Ltd focuses on developing target-specific antibody libraries. The company has evolved its strategies to enhance its capabilities in drug discovery, specifically addressing G-protein coupled receptors and ion channels. The company operates independently and was established by founder Ben H.Antiverse specializes in the design of target-specific antibody libraries engineered to address complex drug targets, particularly G-protein coupled receptors and ion channels. By employing advanced machine learning techniques alongside cutting-edge cell line engineering, Antiverse creates innovative de novo antibody therapeutics. The company aims to enhance the efficiency of the antibody discovery process, enabling clients to identify functional binders within a six-month timeframe.Antiverse generates revenue through strategic partnerships and collaborations with leading pharmaceutical companies. The business model primarily involves B2B transactions structured around tailored programs to meet specific client needs. It earns revenue from the provision of antibody design services, which encompass various phases of drug development including custom antibody libraries and validation processes. Antiverse engages in project-based contracts with clients, negotiating based on the complexity of specific projects, focusing on delivering scientifically driven results.
Who invested in Antiverse
13 investors across 4 rounds
See all investors in Antiverse
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Antiverse
Who invested in Antiverse?
Antiverse has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Antiverse raised?
Antiverse has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Antiverse last raise money?
Antiverse's most recent round on record is a Series A, in Mar 2026.
What does Antiverse do?
Antiverse Ltd, based in the UK, specializes in innovative antibody design, utilizing advanced machine learning and engineering techniques to create therapeutics targeting complex drug targets.
Where is Antiverse headquartered?
Antiverse is headquartered in Cardiff, UK.
Which VCs invest in companies like Antiverse?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Antiverse's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Antiverse? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.